key: cord-1044322-smtyaea1
authors: Herings, R. M.; Swart, K. M. A.; van der Zeijst, B.; van der Heijden, A. A.; van der Velden, K.; Hiddink, E. G.; Heymans, M. W.; Herings, R. A. R.; van Hout, H. P. J.; Beulens, J. J. W.; Nijpels, G.; Elders, P. J. M.
title: Development and validation of an algorithm to estimate the risk of severe complications of COVID-19 to prioritise vaccination
date: 2021-02-08
journal: nan
DOI: 10.1101/2021.02.05.21251197
sha: 61c1c8889fecb31a6cbab29d4afd2d15f4ee9808
doc_id: 1044322
cord_uid: smtyaea1

Objective: To develop an algorithm (sCOVID) to predict the risk of severe complications of COVID-19 in a community-dwelling population to optimise vaccination scenarios. Design: Population based cohort study Setting: 264 Dutch general practices contributing to the NL-COVID database Participants: 6074 people aged 0-99 diagnosed with COVID-19 Main outcome measures: Severe complications (hospitalisation, institutionalisation, death). The algorithm was developed from a training dataset comprising 70% of the patients and validated in the remaining 30%. Potential predictor variables included age, sex, a chronic co-morbidity score (CCS) based on risk factors for COVID-19 complications as defined by the National Institute of Public Health and the Environment (RIVM), obesity, neighborhood deprivation score (NDS), first or second COVID wave, and confirmation test. Six different population vaccination scenarios were explored: 1) random (naive), 2) random for persons above 60 years (60plus), 3) oldest patients first in age bands of five years (oldest first), 4) target population of the annual influenza vaccination program (influenza) and 5) those 25-65 years of age first (worker), and 6) risk-based using the prediction algorithm (sCOVID). For each vaccination strategy the amount of vaccinations needed to reach a 50% reduction of severe complications was calculated. Results: Severe complications were reported in 243 (4.8%) people with 59 (20.3%) nursing home admissions, 181 (62.2%) hospitalisations and 51 (17.5%) deaths. The algorithm included age, sex, CCS, NDS, wave, and confirmation test with a c statistic of 0.91 (95% CI 0.88-0.94) in the validation set. Applied to different vaccination scenarios, the proportion of people needed to be vaccinated to reach a 50% reduction of severe complications was 67.5%, 50.0%, 26.1%, 16.0%, 10.0%, and 8.4% for the worker, naive, infuenza, 60plus, oldest first, and sCOVID scenarios respectively. Conclusion: COVID-19 related severe complications will be reduced most efficiently when vaccinations are risk-based, prioritizing the highest risk group using the sCOVID algorithm. The vaccination scenario, prioritising oldest people in age bands of 5 years down to 60 years of age, performed second best. The sCOVID algorithm can readily be applied to identify persons with highest risks from data in the electronic health records of GPs.

performed second best. The sCOVID algorithm can readily be applied to identify persons with highest risks from data in the electronic health records of GPs.

What is already known on this topic?  Severe COVID-19 complications may be reduced when persons at the highest risk will be vaccinated first.

 To identify persons at a high risk for hospitalization or death in the general population, a limited number of prediction algorithms have been developed.

 Most of these algorithms were based on data from the first wave of infections (spring 2020) when widespread testing was not always possible, limiting the usefulness of these algorithms.

In the Netherlands, as in many other countries, the SARS-CoV-2 outbreak had severe consequences from March 2020 onwards. The fast spread of the infection and the unexpected severe complications required, in the absence of treatment, hospitalisation for many days in intensive care units (ICU), thereby occupying all available ICU beds in the Dutch hospitals. This urged the Dutch government to install social distancing measures including a lock-down. Although the number of hospitalisations dropped fast in the summer, a sudden increase started in August 2020 leading to a second lockdown on December 15th, 2020 and a curfew on January 23th, 2021. The still limited capacity of available ICU beds, the unpredictable course of the COVID-19 infections, the limited knowledge on how these infections spread among the population, the absence of proper treatments, and the in time and location unsuspected flare-ups of infections, paralysed the Dutch care system and economy.

To prioritise high risk individuals for vaccination or shielding from corona infections, or to start treatment in primary care as soon as possible, accurate identification of patients at risk for severe COVID-19 is of utmost importance. This requires living, accurate risk prediction algorithms, that are easy to apply in General Practice as suggested by Clift et al. 1 . Initially, prediction algorithms for mortality or progression to severe disease were mainly developed for hospitalised patients. [2] [3] [4] In the meantime several prediction algorithms for COVID-19 infected patients in the general population have been developed. [4] [5] [6] Although the performance of these algorithms is fairly good, they have to deal with bias due to country specific policy measures that change in time. This is in part because these studies were conducted based in the first wave of the infections, when testing was scarce and policy measures were still in its infancy.

By now vaccines have become available and vaccination campaigns are ongoing but the shortage of vaccines limits the out roll of these campaigns. 7 Efforts to prioritise risk groups for vaccination are ongoing, focusing on populations with the highest risk of COVID-19 complications. 8 The development of our algorithm was aimed to provide predictions for subpopulations at risk for severe COVID-19 infections leading to hospitalisation, institutionalisation or death. The prediction algorithms is based on data of the Dutch NL-COVID database, containing nationwide geo-All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251197 doi: medRxiv preprint demographical and medical data. 9 Building on this algorithm, that can be updated and adapted regularly, we estimated the effectiveness of six different scenarios for vaccination of high-risk persons in order to prevent severe COVID-19 complications.

This cohort study was performed by using data from an extensive and representative general practice population database in the Netherlands.

Data were obtained from GP practices who reported information of the diagnoses and comorbidities of patients suffering from COVID-19 in the NL-COVID database. This database was set up in April 2020 as a collaborative initiative of general practitioners, public health specialists, virologists, epidemiologists, data scientists, data specialists, privacy specialists, and ICT companies providing Electronic Health Records (EHR). Together the ICT companies cover about 95% of all GP practices in the Netherlands. GPs were asked to complete a brief questionnaire protocol for patients suffering from COVID-19 in their ICT systems. From a total of 264 practices (~5% of all Dutch GP practices), both questionnaire data and EHR records with information regarding selected comorbidities were included in this study. Data until January 21th, 2021 were used.

The selected comorbidities (Supplementary Table 1) were those indicated by the National Institute for Public Health and the Environment (RIVM) to be relevant for the prognosis of severe outcomes of COVID-19 infections. 10 The following information was collected on a daily basis: a diagnosis of COVID-19 and whether the diagnosis was confirmed with a PCR test, the severity of the infection defined as treated at home, treated in a hospital or special care institution or death from COVID-19. Updates of the patient's status was recorded using the same form. For this paper we used the last status report. In addition, age, gender, body mass index (BMI), and postal code were collected from the electronic registries of the GP. The neighborhood deprivation score (NDS) was based on the quartile distribution of relative wealth of the neighborhood as derived by Statistics Netherlands. 11 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in There were no missing data in the NL-COVID database: questionnaire data were complete and the registration of comorbidities in the EHR was considered to be complete as well.

A cohort study was performed among patients registered in the NL-COVID database suffering from COVID-19 symptoms certified by their GP.

The primary outcome was the occurrence of severe complicated COVID-19 disease defined as hospitalisation, institutionalization or death.

Predictors included age and sex, the NDS, body mass index (BMI ≥ 30 kg/m 2 ), the period of registration (before or after August 2020) as first of the second wave, whether the diagnosis was confirmed with a PCR test or CT-Scan, and a chronic comorbidity score (CCS). The CCS was based on the chronic diseases identified as predictors for complications of COVID-19 infection by the National Institute for Public Health and the Environment. 10 The comorbidities were mapped to the ICPC coding system used in Dutch GP practices and subsequently grouped into nine disease clusters (Appendix A). A patient was scored in each of these respective disease clusters and assigned a point per cluster. For example, a patient suffering from epilepsy and diabetes scored a point in the category neurological diseases and a point for diabetes yielding a CCS of 2.

The prediction models yield a probability that a COVID-19 patient develops a severe complication. In a single normalized Dutch GP practice (N= 2090 patients) the summarised sCOVID predicted probabilities is 85. It is assumed that if all patients would be infected with COVID-19, an expected 85 patients would develop severe COVID-19 complications. We further assumed that this probability can be reset to (almost) zero by vaccination, or by shielding patients from contact with others. By vaccination or shielding of the 10 highest-ranked patients, ranging from a probability 0.64 to 0.45, 85 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Depending on the vaccination coverage and the policy who to vaccinate (scenario), the number of patients developing severe complications can be estimated for different vaccination scenarios.

The impact of the vaccination strategy can be followed in time by division of the summarized probabilities Pt divided by B as 100% times Pt/B yielding the percentage expected decrease in severe complications at a given percentage of the population vaccinated. The vaccination coverage needed for a 50% decrease of hospitalization was defined as VC50 as a measure of the efficiency of a particular hypothetical vaccination or shielding scenario. We explored and compared six different hypothetical vaccination scenarios. A first scenario was defined as a naive scenario, a scenario in the absence of any policy, i.e. inhabitants are randomly vaccinated. A second scenario was defined as a plus60 scenario where all inhabitants, 60 years of age or older are randomly vaccinated, followed by random vaccination of those under 60 years of age (also random). A third scenario (oldest first) prioritised vaccination from the oldest down from 100 to 60 years of age in age bands of 5 years.

Within the respective age bands, allocation is random. A fourth scenario was defined as the influenza scenario. Here, patients with an indication for flu vaccination are prioritized for vaccination. A fifth scenario (worker) prioritized random vaccination of inhabitants 25-65 years of age. The six and the last scenario was based on the sCOVID risk ranking algorithm, the sCOVID scenario. Here, we start vaccination based on the absolute risk ranking, the patient with the highest risk first, followed by the second patient in line etc etc.

LASSO regression analysis was used to select predictors in the model and to estimate and shrink regression coefficients. Ten-fold cross validation was used to estimate the optimal shrinkage factor (λ) used in the LASSO regression, such that the sum of the squared residuals was minimised. Age was included as quadratic function. The final regression formula allowed calculation of predicted probabilities for each registered patient at their GP. We randomly allocated 70% of the patients in a All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251197 doi: medRxiv preprint training dataset to develop the model. The other 30% of the patients was allocated into a validation dataset. We assessed the model performance in terms of discrimination and calibration in the validation set. Discrimination was assessed using the c-statistic. The c-statistic indicates the extent to which the model can distinguish between a patient with and without the outcome and varies between 0.5 and 1. Calibration was assessed using calibration plots showing the predicted risk against the observed frequency of the study population's outcome using ten risk groups. Goodness of fit was assessed with the Brier score to quantify the difference between the observed and fitted probability ranging for 0-1 with a score of 0 representing the best model. 12 R version 4.0.2., GLMNET package 

The characteristics of COVID-19 patients recorded in the first and second time period differed in age, baseline risk, frequency of testing and region. The percentage of people developing severe complications dropped from 8.5% in the first period in the Spring 2020 to 2.5% in the second time All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251197 doi: medRxiv preprint period in the Autumn 2020 which was reflected in institutionalisation, hospitalisation, and death. In the first wave, infected patients were from older age groups, whereas relatively more adolescents, 12-19 years of age, were reported in the second wave. The proportion of patients recorded with a positive COVID-19 test increased from 63% in the first wave to 95% in the second wave. The general characteristics are presented in Table 1 . Most of the patients with severe complications suffered from cardiovascular conditions (64.6%) and other chronic conditions such as diabetes, neurological diseases (i.e., dementia, Parkinson's diseases) and lung disease. Almost 80% of patients with severe complications suffered from at least one chronic disease. More than 62% had multiple chronic conditions. The characteristics of the training and validation set is shown in table 2.

The predictor variables in the final COVID-19 models included age, sex, positive test result, period (first or second wave), NDS, obesity and the CCS ( Table 3 ). The strongest predictors included age, NDS, the time period, a positive PCR test and male sex. Obesity was eliminated by the LASSO predictor selection. The final model showed a very good calibration and fit. Figure 1 perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in year-old woman without any chronic condition living in a neighborhood with a high socioeconomic status.

The results of six prioritising scenario analyses were obtained by deploying the different algorithms to 300 randomly selected, fully anonymised GP practices, including data from 1.2 million inhabitants.

The results for the six scenarios are plotted in Figure 5 and summarized in Table 4 

Using data from the NL-COVID database an algorithm was developed to predict the probability of patients developing severe complications once infected with COVID-19 using EHR records from general practices. This sCOVID algorithm, which can be deployed in all Dutch GP practices, showed a very good performance in terms of discrimination (c-index: 0.91) and calibration and can be used to rank the most susceptible patients for prioritisation of vaccinations. Our vaccination scenarios showed that ranking and vaccinating patients based on their complication risk (sCOVID scenario) would be the most efficient vaccination scenario to reduce hospitalisation and deaths. The second-best scenario was to vaccinate the oldest people first in consecutive order. With shortage of vaccines, the most vulnerable patients and not the oldest patients are prioritized.

The sCOVID risk models yields a high discrimination rate (c-statistic = 0.91). Calibration plots show a good fit in all risk categories, although the lowest risks were most challenging to estimate due, to the All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251197 doi: medRxiv preprint limited numbers of patients developing severe complications. These results are similar to those of other prediction algorithms. Two earlier studies developed prediction algorithms for hospitalisation and/or death due to COVID-19 infection show similar prognostic performance. 4 5 The major predictors, selected by the LASSO procedures, were higher age, male gender, the number of chronic comorbidities but also a positive test result and neighborhood deprivation status. comorbidities. More than 60% of the patients with severe complications suffered from more than one chronic condition against less than 20% of the those without comorbidities. Therefore, we preferred to include a chronic disease summary score to come to a more comprehensive and practical algorithm.

Moreover, from a clinical perspective, our sample size was relatively small and would exclude rare but clinically relevant outcomes.

Estimating the risk of severe COVID-19 complications is permanently subject to changing policy measures and interventions to shield high-risk people by vaccinations. 7, 8 The time biases caused by these measures and interventions are complex and difficult to unravel. First analyses confirmed suggestions from Clift et al. that these time biases are indeed present, 4 showing an age and sexadjusted 3-5 times lower complication rate compared to the patients in the first wave. Estimates, needed to predict hospitalisation and or death, therefore need permanent recalibration of the prediction algorithms. Such recalibration is necessary to monitor the effect of policy intervention on managing care capacity. The infrastructure of the NL-COVID database permits the recalibration on a regional and daily basis.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

The NL-COVID database also has limitations and strengths. First, we have substantial underreporting of positive cases since our 264 registration practices consisting of about 5% of all GP practices only reported 0.7% of the registered cases. This is explained by several factors: first, practices enrolled into the program over time and some practices only joined the program and the end of 2021. Second, COVID-19 testing was done by the regional health authorities (GGD) whereas the administrations of the GGD were not linked with the GP administration. Therefore our registration relies on whether the patient contacted the GP and whether the GP registered the patient. This makes it likely that we have a selection bias towards the more severe disease manifestations of the COVID-19 infection. Also our prediction partly relied on the judgement of the GP whether a patient was COVID 19 positive (in case of lacking test results). It should therefore be stressed that absolute estimates risk estimates to develop severe complications should be interpreted with care only by health care professionals for prioritizing strategies. A weakness of the sCOVID scenario is that we did not perform an external validation. The large number of GP practices that came from all over the country and the good testing characteristics of the validation set, makes it likely that the accuracy of the scenarios is adequate. For the comparison of the different scenarios this has no importance since they were compared in the same sample.

A first strength was the coverage and representativity of the practices most strongly confronted with the pandemic. The first wave of COVID-19 hit hard in the southern part of the country and most participating practices were situated here. Second, we used training and validations samples to estimate the accuracy of the algorithms. Third, this study is the first to demonstrate the potential impact and efficiency of more and less targeted vaccinations scenarios. Fourth, the prediction algorithm can be adapted, updated and validated on a daily basis and learn from new insights and policy measures.

Our study showed that within the framework of privacy regulations, COVID-19 infections and consequences can be monitored fast, efficiently and safe on a very detailed local levels and on a dayto-day basis using country wide data from currently available IT systems in GP practice. The costs of All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251197 doi: medRxiv preprint such a database are relatively low. Insight can be generated that help GPs and involved regional and local health authorities to shield patients from infection and to reduce hospitalisation and death very efficiently in a selected group of persons with the highest risks. Moreover, such database may demonstrate and underpin the effectiveness and efficiency of policy measures, to plan and manage care facilities. Secondly, the prediction accuracy could be improved with flexible access to the complete GP patient dossier and linkage to hospital admission under strict compliance with the GDPR to adapt and improve the algorithms if new insights become available. The vaccination scenarios show that in case of remaining shortage of vaccines, vaccination base on the sCOVID scenario performs best with a consecutive age based scenario as second best. Hybrid scenarios that do not follow the risk of COVID-19 complications have worse performances for example the influence scenario in which a combination of age and influenza risk is combined. Currently, vaccination in the Netherlands is performed from a practical perspective based on factors not only related to COVID risk complications. This makes it likely that more efficient scenarios are thinkable. In conclusion, the sCOVID algorithm has been developed to predict which patients are at high risk to develop severe complications due to COVID-19 and showed a good model performance. In remaining shortage of vaccines prioritizing vaccination of patients based on sCOVID risk complications is the most efficient way to reduce hospitalisations, institutionalisations and death.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251197 doi: medRxiv preprint design. RMCH and RARH conducted the statistical analyses. MWH was involved in advanced statistical aspects. All authors contributed to the interpretation of the results. RMCH wrote the first draft of the manuscript. All authors contributed to the critical revision of the manuscript for important intellectual content and approved the final version of the manuscript. RMCH is the guarantor.

All authors have completed the ICMJE uniform disclosure form and declare: RMCH is director of STIZON, an organization that is the processor of the NL-COVID data on behalf of the participating General Practitioners. EGH is an employee of Health base, an independent multidisciplinary foundation active in developing content for medical and pharmaceutical decision support systems, that was also applied for the NL-COVID database. KMAS is employee of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported pharmaco-epidemiological studies for the government, healthcare authorities and pharmaceutical companies. BAMvdZ, AAvdH, KvdV, RARH, MWH, HvH, JWJB, GN, and PMJE declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, and no other relationships or activities that could appear to have influenced the submitted work.

Patients and GPs were asked to consent with data sharing regarding sending data to the NL-COVID database and extract information on the 4-digit postal code level in an anonymized format for public decision making. The procedure was approved and tested for compliance with the general data protection regulation by the privacy and compliance committee of 'Stichting Informatie voorziening voor Zorg en Onderzoek' (STIZON).

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The lead author affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as originally planned (and, if relevant, registered) have been explained.

The data will be available on reasonable request. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in CCS= chronic comorbidity score, NDS = neighborhood deprivation score All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251197 doi: medRxiv preprint

Development and validation of an early warning score (EWAS) for predicting clinical deterioration in patients with coronavirus disease 2019. medRxiv

Early prediction of mortality risk among severe COVID-19 patients using machine learning. medRxiv

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19

Factors associated with COVID-19-related death using OpenSAFELY

WHO. 22nd WHO Regulatory Update on COVID-19: World Health Organization

Strategieën voor COVID-19-vaccinatie. Den Haag: Gezondheidsraad

Sociaaleconomische status van huishoudens in Nederland Den Haag: CBS

The authors like to thank the unconditional support of among which Guus Vaassen and Johan Ruiter